Poxel Announces Product Launch in Japan for TWYMEEG® as Treatment for Type 2 Diabetes
LYON, France--(BUSINESS WIRE)--POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases...








